DFNA5 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DFNA5 monoclonal antibodies for research focused on understanding DFNA5 protein function. DFNA5 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).DFNA5, also known as deafness, autosomal dominant 5, is a gene associated with non-syndromic hearing loss. DFNA5 protein plays a central role in the auditory system, and mutations can lead to significant hearing impairment. Understanding DFNA5 function and mechanisms is essential for developing potential therapeutic strategies for hearing loss. Research has shown that DFNA5 is expressed in various tissues throughout the body, suggesting additional biological functions beyond hearing. Recent studies have highlighted DFNA5's potential involvement in cell death pathways and cancer development. Ongoing investigations continue to uncover new aspects of DFNA5's biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DFNA5 and its impact on human health.